Sinopharm is setting up production lines to supply up to one billion doses of two COVID-19 vaccines currently being tested on 50,000 people in Phase III trials.
Sinopharm is setting up production lines to supply up to one billion doses of two COVID-19 vaccines currently being tested on 50,000 people in Phase III trials. Sinopharm is currently testing the vaccines in ten countries, including Egypt, Argentina, Jordan, and Peru.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
NewsSinopharm is setting up production lines to supply up to one billion doses of two COVID-19 vaccines currently being tested on 50,000 people in Phase III trials.
View Premium plansBrowse free archive reportsSinopharm is setting up production lines to supply up to one billion doses of two COVID-19 vaccines currently being tested on 50,000 people in Phase III trials. Sinopharm is currently testing the vaccines in ten countries, including Egypt, Argentina, Jordan, and Peru.